Published on
Diagnostic Tests: C-Peptide

Overview — What This Test Is

The C-peptide test measures the serum level of C-peptide, a byproduct released when proinsulin is cleaved into insulin within pancreatic β-cells. Because C-peptide is secreted only with endogenous insulin and is absent in injected (exogenous) insulin, it is the best test for distinguishing endogenous from exogenous hyperinsulinemia in patients presenting with hypoglycemia.


Interpretation of Low C-Peptide Levels

Low C-peptide levels in the setting of hypoglycemia indicate exogenous insulin administration. In this situation, insulin levels are elevated, but C-peptide is suppressed because the insulin is being injected rather than produced by the pancreas. This finding is classic for factitious hypoglycemia, often due to insulin abuse, and may be seen in patients with psychiatric disease or repeated unexplained hospital visits.

Interpretation of High C-Peptide Levels

High C-peptide levels reflect endogenous insulin production. This occurs when the pancreas is actively secreting insulin, such as in:


  • Insulinoma
  • Sulfonylurea use, which stimulates pancreatic insulin release

In these cases, both insulin and C-peptide levels are elevated during episodes of hypoglycemia.

When to Choose a C-Peptide Level

You should answer C-peptide level when a patient presents with:


  • Unexplained hypoglycemia
  • Elevated insulin levels
  • Recurrent or unexplained hospital admissions
  • Suspicion of factitious disorder or insulin-secreting tumor


In exam questions, C-peptide is the next best diagnostic step to determine the cause of hyperinsulinemic hypoglycemia and to differentiate insulin abuse from endogenous insulin excess.


Picture
0 Comments